S. Moquin

发表

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

Chaim A. Schramm, K. Roskin, T. Kepler, 2013, Nature.

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

Young Do Kwon, Tongqing Zhou, Baoshan Zhang, 2011, Nature.

Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies.

Young Do Kwon, Tongqing Zhou, Baoshan Zhang, 2013, Immunity.

The Epstein-Barr Virus Episome Maneuvers between Nuclear Chromatin Compartments during Reactivation

K. Pollard, J. Miranda, Sean Thomas, 2017, Journal of Virology.

Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease Inhibitors

M. Schirle, J. Tallarico, D. Nomura, 2022, bioRxiv.

Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance

C. Schiffer, D. Bolon, J. Flynn, 2022, Nature Communications.

NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models

G. Bonamy, V. Sasseville, Yen-Liang Chen, 2021, Science Translational Medicine.

Novel molecular insights into Epstein-Barr virus reactivation

S. Moquin, 2017 .

Systematic analyses of the resistance potential of drugs targeting SARS-CoV-2 main protease

C. Schiffer, D. Bolon, J. Flynn, 2023, bioRxiv.

PGV04, an HIV-1 gp120 CD4 Binding Site Antibody, Is Broad and Potent in Neutralization but Does Not Induce Conformational Changes Characteristic of CD4

Tongqing Zhou, Terri Wrin, Peter D. Kwong, 2012, Journal of Virology.

Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization

Tongqing Zhou, Lynn Morris, Gwo-Yu Chuang, 2013, Science.

PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter

J. Miranda, S. Moquin, I. Tempera, 2017, Virology.

Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors

Cinque S. Soto, J. Mullikin, B. Haynes, 2015, Cell.

Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps

J. Miranda, S. Moquin, Samantha G. Fernandez, 2017, The Journal of Biological Chemistry.

Somatic Hypermutation-Induced Changes in the Structure and Dynamics of HIV-1 Broadly Neutralizing Antibodies.

Cinque S. Soto, J. Mascola, Baoshan Zhang, 2016, Structure.

Bacterial diversity of bryophyte-dominant biological soil crusts and associated mites

S. Moquin, C. Takacs-Vesbach, S. Brantley, 2012 .

Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms

C. Schiffer, D. Bolon, J. Flynn, 2022, bioRxiv.

Symbiodinium diversity in the soft coral Heteroxenia sp. and its nudibranch predator Phyllodesmium lizardensis

S. Moquin, D. Colman, C. Takacs-Vesbach, 2012, Coral Reefs.

Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses

C. Schiffer, S. Moquin, E. Ornelas, 2023, bioRxiv.

Outer Domain of HIV-1 gp120: Antigenic Optimization, Structural Malleability, and Crystal Structure with Antibody VRC-PG04

J. Mascola, G. Nabel, T. Zhou, 2012, Journal of Virology.